Halted Alzheimer’s drug trials renew questions about causes of the disease

October 20th, 2010 by admin

Two clinical trials of a potential Alzheimer’s drug were halted this week, highlighting circulating skepticism about the hypothesis that amyloid beta plaque is a major factor in the disease’s genesis. [More]

Add to diggAdd to StumbleUponAdd to RedditAdd to FacebookAdd to del.icio.usEmail this Article

Alzheimer’s disease - Clinical trial - Beta amyloid - Health - Conditions and Diseases

More: continued here

Vitamin B12 May Reduce Risk Of Alzheimer’s Disease

October 20th, 2010 by admin

CMS Could Save Billions By Changing Payment, Delivery Methods

October 20th, 2010 by admin

Web-based application to project the burden of Alzheimer’s disease

October 20th, 2010 by admin

New Service Aims to Match Alzheimer’s Patients, Clinical Trials

October 20th, 2010 by admin

Memory Loss, Safety And Confusion Top Alzheimer’s Caregivers’ Concerns, National Survey Reveals

October 20th, 2010 by admin

ASA: Pre-Surgical Aspirin Tied to Fewer Cardiocerebral Events

October 20th, 2010 by admin

Hypothermia predicts mortality in critically ill elderly patients with sepsis

October 20th, 2010 by admin

Morphological Changes of the Human Purkinje Cells and Deposition of Neuritic Plaques and Neurofibrillary Tangles on the Cerebellar Cortex of Alzheimer’s Disease

October 20th, 2010 by admin

Research Brief: More NMDA Receptor Gene Variants in CNS Disease

October 20th, 2010 by admin